Immunosuppression for immunodeficiency: Getting smarter - 06/12/18
Doi : 10.1016/j.jaci.2018.10.006
Lucy Duan, MD a, b, Eyal Grunebaum, MD a, b, ⁎ 
a Division of Immunology and Allergy, Hospital for Sick Children, Toronto, Ontario, Canada
b Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada
∗Corresponding author: Eyal Grunebaum, MD, Division of Immunology and Allergy, Hospital for Sick Children, 555 University Ave, Toronto, Ontario M5G 1X8, Canada.Division of Immunology and AllergyHospital for Sick Children555 University AveTorontoOntarioM5G 1X8Canada
Key words : Inborn errors of immunity, cytotoxic T lymphocyte–associated antigen 4, signal transducer and activator of transcription, primary immunodeficiency diseases, immunosuppression, hematopoietic stem cell transplantation
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 6
P. 1762 - décembre 2018 Retour au numéro
Article précédent
- Influenza immunization in patients with common variable immunodeficiency
- Ricardo U. Sorensen, Luke A. Wall
- Managing Asthma in Pregnancy (MAP) trial: FENO levels and childhood asthma
- Matthew Morten, Adam Collison, Vanessa E. Murphy, Daniel Barker, Christopher Oldmeadow, John Attia, Joseph Meredith, Heather Powell, Paul D. Robinson, Peter D. Sly, Peter G. Gibson, Joerg Mattes
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?